Julia Moore is a Partner at Breakout Ventures, investing in early stage life sciences companies. Julia and her partners also run Breakout Labs, a seed fund within Peter Thiel’s foundation that focuses on breakthrough technologies across hard sciences. Julia has spent her career investing in, analyzing and operating life sciences companies. Earlier in her career, she was an investor with Kearny Venture Partners, a research analyst at Thomas Weisel Partners, the head of business development and strategy at TriVascular (NASDAQ: TRIV; Acquired by Endologix) and at an institute at Stanford. She is a graduate of the University of Virginia, with a degree in finance from the McIntire School of Business and Bioethics from the College of Arts and Sciences. Julia is also a Kauffman Fellow.
